Back to companies

InflaRx N.V.

IFRXDENASDAQPharmaceuticals & Healthcare

InflaRx N.V.

Revenue
€29,331
YoY -82.3%
Operating income
—
FY2025
Employees
—
Founded
—

Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API